IFNG and allergic rhinitis: Most studies have focused on mesenchymal stem cells (MSCs) derived from bone marrow, umbilical cord, or other tissues in animal models of allergic rhinitis, reporting reduced symptoms, decreased IgE, IL-4, IL-5, and IL-10, and increased interferon gamma (IFN-γ) following treatment (27–30).